In such a manner, TLR2 tolerance and inhibition of T1D development in NOD mice could be achieved by repeated administration of the TLR2 agonist Pam3CSK4 or zymosan (11, 13). The gene discussed is TLR2; the disease is type 1 diabetes mellitus.